tRF-31 and HIPK2 in age-related cataract: a look at eye tissue and surgery outcomes
Official title: Biphasic Dynamics of the tRNA-derived Small RNA tRF-31 Set the Lens Oxidative Survival Threshold by Restraining HIPK2-mediated Dual-track Lethality in Age-related Cataract
Run by Second Affiliated Hospital, Zhejiang University, School of Medicine · NCT07672899 · Data updated 2026-11-12
This observational study tests whether the tRF-31/HIPK2 signaling axis in the eye relates to cataract severity in adults with age-related cataract.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Second Affiliated Hospital, Zhejiang University, School of Medicine Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Status | Recruiting |
| Started | June 17, 2026 |
| Main results expected | August 16, 2026 |
| Study ends | September 16, 2026 |
| Registry record updated | June 29, 2026 |
| Trial ID | NCT07672899 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 with clinically diagnosed age-related cataract who are scheduled for routine cataract extraction with IOL and have completed preoperative corneal endothelial assessments.
✕Probably not a fit
Patients whose cataract severity does not correlate with the tRF-31/HIPK2 axis or whose tissue sampling shows no meaningful data may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study will collect anterior lens capsule tissue from adults with age-related cataract undergoing standard phacoemulsification with IOL. Researchers will measure tRF-31 expression and HIPK2 levels and examine their relationship to Emery-Little cataract grade. Preoperative eye tests, including corneal endothelial cell counts, will be performed, and oxidative stress in the anterior segment will be considered for potential effects on the corneal endothelium. The work is purely observational and uses tissue already removed during routine surgery. No experimental interventions beyond standard care are involved.
Why it matters
Potential benefit: If a link between tRF-31/HIPK2 and cataract severity is found, it could guide future biomarker development and personalized management of ARC.
How similar studies have gone: Previous research has explored noncoding RNA and signaling pathways in ocular diseases, with some success; this work extends those concepts to ARC in an observational framework.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients older than 18 years. Clinically diagnosed with age-related cataract (ARC) and have clear surgical indications for routine phacoemulsification combined with intraocular lens (IOL) implantation. Scheduled to undergo cataract extraction and intraocular lens implantation. Completed routine preoperative corneal endothelial specular microscopy, providing objective data including cell density, coefficient of variation of cell area, and the proportion of hexagonal cells. Provided signed written informed consent. Exclusion Criteria: History of ocular trauma, glaucoma, episodes of active uveitis, or previous intraocular surgery. Presence of severe systemic diseases rendering the patient unsuitable for surgery. Poor patient compliance or coexisting psychiatric disorders. Severe systemic metabolic syndromes (e.g., diabetes). Diagnosis of high myopia. Current participation in other clinical trials or likelihood of being lost to follow-up.
Where it's running
-
Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Study coordinator: Yueyang Zhong
- Email: yyzbzhong@zju.edu.cn
- Phone: +86+ 18868125901
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rotational Stability of the Acunex Vario Toric
This study tests whether the Acunex Vario toric extended-depth-of-focus intraocular lens stays stable in rotation and effectively reduces astigmatism for people undergoing cataract surgery.
-
Anterior segment anatomy assessment with swept-source OCT in eye surgery patients
This study tests whether swept-source OCT can detail front-eye anatomy in patients undergoing anterior segment eye surgery.
-
MiLOOP-assisted cataract surgery for dense cataracts
In people with dense cataracts, this study tests whether using the miLOOP device during cataract surgery can protect corneal cells and reduce ultrasound energy, compared with standard surgery.
-
Visual adaptation and quality of life after different IOL implantation options
This study follows adults who have cataracts and receive bilateral multifocal or mixed IOLs to see how their vision and daily life improve over 6 months.
-
Corneal Biomechanics and Surgical Astigmatism after Cataract Surgery in Pseudoexfoliation
This study tests how the cornea's biomechanical properties before cataract surgery relate to the amount of blinking surgically induced astigmatism, comparing people with pseudoexfoliation to those without.
-
Neuroplastic pain education and guided breathing during awake cataract surgery
This trial tests whether the STEIN Protocol, a non-drug approach with pain education, guided imagery, and paced breathing, helps adults having cataract surgery require less pain medicine and feel less anxious.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.